Zymeworks Inc. (NASDAQ:ZYME) Q1 2026 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Zymeworks Inc. First Quarter 2026 Results Conference Call. At this time, all participants are in a listen-only mode.
Zymeworks Inc. (ZYME)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | EcoR1 Capital Oleg Nodelman | 22,970,388 | $575,178,516 | 24.41% | |
| 2. | Rubric Capital Management David Rosen | 7,000,000 | $175,280,000 | +22% | 1.86% |
| 3. | Biotechnology Value Fund / BVF Inc Mark Lampert | 3,734,142 | $93,502,916 | -6% | 2.98% |
| 4. | Perceptive Advisors Joseph Edelman | 3,510,078 | $87,892,353 | +8% | 1.72% |
| 5. | Citadel Investment Group Ken Griffin | 1,150,018 | $28,796,451 | +351% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.78 | 5,919 | $69,738.25 | 17,883,908 | 2025-05-19 | Filing | |
| $11.43 | 49,502 | $565,847.46 | 17,877,989 | 2025-05-15 | Filing | |
| $11.52 | 54,760 | $630,818.77 | 17,828,487 | 2025-04-17 | Filing | |
| $11.16 | 73,953 | $825,589.11 | 17,773,727 | 2025-04-16 | Filing | |
| $11.17 | 196,438 | $2,193,799.94 | 17,699,774 | 2025-04-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.67 | 6,120 | $138,761.82 | 132,913 | 2026-01-12 | Filing | |
| $22.67 | 9,310 | $211,090.29 | 26,708 | 2026-01-12 | Filing | |
| $22.67 | 9,560 | $216,758.66 | 48,497 | 2026-01-12 | Filing | |
| $22.67 | 30,424 | $689,818.56 | 226,842 | 2026-01-12 | Filing | |
| $25.10 | 10,538 | $264,471.13 | 18,352 | 2026-01-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,553,888 | $114,029,354 | 0% | |
| 2. | 2,480,568 | $62,113,426 | 0% | |
| 3. | 1,908,039 | $47,777,297 | 0.06% | |
| 4. | 1,705,580 | $42,707,723 | 0% | |
| 5. | 1,139,135 | $28,518,914 | 0.01% |
News See All
Zymeworks Inc. (NASDAQ:ZYME) Q4 2025 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to the Zymeworks Inc. Fourth Quarter 2025 Results Conference Call and Webcast.
Zymeworks Inc. (NASDAQ:ZYME) Q3 2025 Earnings Call Transcript
Shrinal Inamdar: Thank you, operator. Good afternoon, everyone. Thank you for joining our third quarter 2025 results conference call.
Zymeworks Inc. (NASDAQ:ZYME) Q2 2025 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to Zymeworks Second Quarter 2025 Results Conference Call and Webcast.
Zymeworks Inc. (NYSE:ZYME) Q1 2025 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to Zymeworks First Quarter 2025 Results Conference Call and Webcast.
Zymeworks Inc. (NYSE:ZYME) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to Zymeworks Fourth Quarter and Year-end 2024 Results Conference Call and Webcast.
Zymeworks Inc. (NYSE:ZYME) Q3 2024 Earnings Call Transcript
Operator: Hello. Thank you for standing by. This is the conference operator. Welcome to Zymeworks First Quarter 2024 Results Conference Call and Webcast.
Zymeworks Inc. (NYSE:ZYME) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to Zymeworks Second Quarter 2024 Results Conference Call and Webcast.
Zymeworks Inc. (NYSE:ZYME) Q1 2024 Earnings Call Transcript
Zymeworks Inc. misses on earnings expectations. Reported EPS is $-0.41513 EPS, expectations were $-0.31. Zymeworks Inc.
12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 12 most undervalued biotech stocks to buy according to hedge funds.